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autoimmune response against a3(IV) collagen occurring in
all mouse (but not human) tubular basement membranes.
Alternatively, mononuclear interstitial inﬁltrates may be
secondary to nephrotic-range proteinuria. Of note, the pre-
dominant inﬂammatory cells in human membranous nephro-
pathy are interstitial monocytes/macrophages and CD4(þ )
T cells.4 Moreover, their numbers correlate with renal impair-
ment at the time of biopsy and progressive renal impairment
over 5 years, suggesting that progression toward renal failure
in membranous nephropathy may be driven mainly by cell-
mediated immunity.4 Future studies expanding on the ﬁndings
of Hopfer et al. are needed to determine whether interstitial
mononuclear inﬁltrates are indeed harbingers of renal failure
in membranous nephropathy.
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The Authors Reply: In their letter1 and in a recent publica-
tion,2 Borza and Fogo report that DBA/1 mice immunized
twice with recombinant human noncollagenous domain 1 of
a3(IV) collagen (a3(IV)-NC1) developed severe nephrotic
syndrome. Histological examination revealed membranous
glomerulonephritis (GN) with only a few glomerular crescents.
The protocol deployed in our studies3,4 uses four immuniza-
tions instead of two. After a stage of membranous GN, mice
rapidly progress to a necrotizing crescentic GN accompanied
by tubulointerstitial damage with massive inﬁltration of
macrophages and, to a lesser extent, T cells. In our study, two
immunizations were also not sufﬁcient to induce crescentic
GN (unpublished). Thus, continuous immunizations appear
to be necessary for the switch to crescentic GN.
Borza and Fogo suggest that the interstitial inﬁltrates may
be a true autoimmune response against mouse tubular base-
ment membranes. In contrast, we favor the hypothesis that
a3IV-NC1–speciﬁc T cells are the driving force triggering the
switch from membranous to crescentic GN. As recently pro-
posed by Heymann et al.,5 antigen from damaged glomeruli
may spread into the interstitium and become available for
antigen presentation, causing local T-cell activation and sub-
sequent recruitment and activation of macrophages. We think
that this mechanism is more likely because the glomerular
basement membranes show extensive alterations while the
tubular basement membranes don’t. In our view, the biphasic
course of our animal model with a rapid increase of mononu-
clear cells in the context of crescentic GN rather than a chronic
accumulation does not support the concept of mononuclear
cells as a harbinger of renal failure in membranous GN.
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Association between dialysis
schedule and mortality in
maintenance hemodialysis
To the Editor: This is with reference to the recent article by
Zhang et al.1 that studied the association between the dialysis
schedule and the day of the week of all-cause mortality in
maintenance hemodialysis (HD) patients. We undertook a
retrospective analysis of all chronic HD patients (treated for
46 months) dialyzed in a single UK region (Northern
Ireland, population¼ 1.8 million) in order to study this
relationship. All deaths between 2007 and 2011 were recorded
(n¼ 247; mean age¼ 70.2 years; 62.7% males). The mean
duration of HD was 55 months (range 6–296 months) and
the commonest primary renal diagnosis was diabetic
nephropathy (22%). We found a relative increase in mortality
on the ﬁrst dialysis schedule day, i.e., Monday for
Monday–Wednesday–Friday (MWF) schedule and Tuesday
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for Tuesday–Thursday–Saturday (TTS) schedule. Interest-
ingly, we also found that this mortality plateaued over the
week, with a more modest rise again on the third dialysis
schedule day, i.e., Friday for the MWF schedule and Saturday
for the TTS schedule (Figure 1). Our study appears to conﬁrm
the interesting observation of heightened all-cause mortality
risk on the ﬁrst and the third dialysis schedule days. It is
therefore imperative for other regions throughout the world
to study for this association also, for, if conﬁrmed, it may have
signiﬁcant implications for the timing and duration of HD
sessions in the future.
1. Zhang H, Schaubel DE, Kalbfleisch JD et al. Dialysis outcomes and analysis
of practice patterns suggests the dialysis schedule affects day-of-week
mortality. Kidney Int 2012; 81: 1108–1115.
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The Authors Reply: We thank Dr Prabhavalkar et al.1 for
sharing their results related to our study of the relationship
between dialysis schedule and weekday-speciﬁc mortality.2 On
the basis of experience from Northern Ireland, the authors
report elevated all-cause mortality risk on the ﬁrst and last
dialysis days. In our report, we had also observed that
hemodialysis patients in Europe and Japan (but not the United
States) experienced higher mortality on the last day of dialysis
(i.e., Friday for Monday–Wednesday–Friday (MWF); Saturday
for Tuesday–Thursday–Saturday (TTS)).
The analysis of Prabhavalkar et al.1 used a common coding
scheme across both MWF and TTS schedules. Related work by
Zhang3 features a similar approach, with each day of the
dialysis schedule numbered (day 1,y, day 7). With respect to
all-cause mortality, the same parameter is used to represent the
Friday effect for MWF schedule patients and the Saturday
effect for TTS schedule patients (i.e., day 5 of the dialysis
schedule). As shown in Table 1, all-cause mortality was
signiﬁcantly elevated on day 1 in all three regions. Day 5 was
associated with mortality increases that were signiﬁcant in
Japan (P¼ 0.01), near-signiﬁcant in Europe (P¼ 0.07), but
nonsigniﬁcant in the United States. (P¼ 0.41).
We concur with Prabhavalkar et al.1 on the need for future
studies to further understand this ‘late-in-the week’ effect. We
speculate that this could well be the result of progressive
ultraﬁltration during the week, reaching the lowest intradialytic
weight on day 5 with risk of organ ischemia (e.g., myocardial
stunning) as reported by McIntyre.4
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Figure 1 | The total number of deaths on various dialysis
schedule days of the week. D1 is the first dialysis schedule day,
i.e., Monday for the Monday–Wednesday–Friday (MWF) schedule
and Tuesday for the Tuesday–Thursday–Saturday (TTS) schedule,
and D3 is the third dialysis schedule day, i.e., Friday for the MWF
schedule and Saturday for the TTS schedule.
Table 1 |Mortality risk (HR) by dialysis day of week and
Dialysis Outcomes and Practice Patterns Study (DOPPS)
region compared with overall average
United States Europe Japan
Day HRa P-value HR P-value HR P-value
1b 1.40 o0.0001 1.29 0.0004 1.34 0.017
2 0.94 0.19 1.03 0.75 1.14 0.34
3b 0.99 0.86 0.91 0.21 1.06 0.66
4 0.84 0.002 0.81 0.007 0.73 0.055
5b 1.04 0.41 1.14 0.070 1.43 0.010
6 0.90 0.051 0.96 0.58 0.75 0.056
7 0.97 0.49 0.93 0.28 0.79 0.10
Abbreviation: HR, hazard ratio.
aEach day is compared with the average across day 1, y, day 7.
bIndicates day of dialysis.
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